SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

1-Year Outcomes of US TAVR Registry with 5th Generation Balloon Expandable Valves

Dr. Andrés Rodríguez - 26 December, 2024 0

The use of transcatheter aortic valve replacement (TAVR) has extended to younger patients with lower risk severe aortic stenosis (AS) and therefore the improvement...

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Dr. Carlos Fava - 24 December, 2024 0

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

Dr. Omar Tupayachi - 23 December, 2024 0

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: Mavacamten

ACC 2022 | VALOR-HCM: Mavacamten in Adults with Symptomatic Obstructive HCM...

Últimas Noticias

1-Year Outcomes of US TAVR Registry with 5th Generation Balloon Expandable Valves

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

Noticias Institucionales

Hemodynamics and Interventional Cardioangiology Hybrid Training Course SOLACI-CACI

Check out the best images of the El Salvador 2024 Sessions

The El Salvador 2024 Sessions are coming soon

Accesos